Braidwell LP
- SEC CIK
- 0001920938
- Latest filing
- Aug 14, 2026
Holdings in Q3 2024
Holdings as of Sep 30, 2024, filed Nov 14, 2024. Long positions only; changes compare share counts with Q2 2024.
- Positions
- 81
- +6 vs. Q2 2024
- Portfolio value
- $3.53B
- +$340.2M (+10.7%) vs. Q2 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ELEVElevation Acquisition Group Inc. | COM | 473,503 | $284.1K | <0.1% | −2,004,111−80.9% | Reduced | History |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 1,630,542 | $1.14M | <0.1% | −811,962−33.2% | Reduced | History |
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 801,584 | $1.26M | <0.1% | −7,493,366−90.3% | Reduced | History |
| HLVXHilleVax, Inc. | COM | 1,064,000 | $1.87M | 0.1% | +1,064,000 | New | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 217,928 | $2.05M | 0.1% | −1,248,682−85.1% | Reduced | History |
| VERVVerve Therapeutics, Inc. | COM | 623,980 | $3.02M | 0.1% | +623,980 | New | History |
| FULCFulcrum Therapeutics, Inc. | COM | 1,069,158 | $3.82M | 0.1% | +1,069,158 | New | History |
| Cutera Inc232109AD0 | NOTE 2.250% 6/0 | – | $4.04M | 0.1% | – | – | – |
| Cutera Inc232109AG3 | NOTE 4.000% 6/0 | – | $4.98M | 0.1% | – | – | – |
| SKINSkinHealth Systems Inc. | COM CL A | 4,049,694 | $5.83M | 0.2% | −1,070,991−20.9% | Reduced | History |
| LUNGPulmonx Corp | COM | 752,541 | $6.24M | 0.2% | 00.0% | Unchanged | History |
| LXEOLexeo Therapeutics, Inc. | COM | 728,777 | $6.59M | 0.2% | −653,704−47.3% | Reduced | History |
| BBIOBridgeBio Pharma, Inc. | COM | 298,400 | $7.60M | 0.2% | −47,171−13.7% | Reduced | History |
| JSPRJasper Therapeutics, Inc. | COM NEW | 483,300 | $9.09M | 0.3% | +483,300 | New | History |
| XNCRXencor Inc | COM | 466,448 | $9.38M | 0.3% | +466,448 | New | History |
| CSTLCastle Biosciences Inc | COM | 331,986 | $9.47M | 0.3% | −84,114−20.2% | Reduced | History |
| NVRONevro Corp | COM | 1,698,768 | $9.50M | 0.3% | 00.0% | Unchanged | History |
| PODDInsulet Corp | Stock | 42,500 | $9.89M | 0.3% | +42,500 | New | History |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 2,472,806 | $10.0M | 0.3% | +2,472,806 | New | History |
| ALECAlector, Inc. | COM | 2,158,245 | $10.1M | 0.3% | −222,459−9.3% | Reduced | History |
| Haemonetics Corp Mass405024AB6 | NOTE 3/0 | – | $10.6M | 0.3% | – | – | – |
| ORKAOruka Therapeutics, Inc. | COM | 515,726 | $12.6M | 0.4% | +515,726 | New | History |
| CELCCelcuity Inc. | COM | 884,306 | $13.2M | 0.4% | +367,663+71.2% | Added | History |
| FDMT4D Molecular Therapeutics, Inc. | COM | 1,225,448 | $13.2M | 0.4% | +855,990+231.7% | Added | History |
| DNTHDianthus Therapeutics, Inc. | COM | 493,687 | $13.5M | 0.4% | +126,836+34.6% | Added | History |
| BSXBoston Scientific Corp | Stock | 189,200 | $15.9M | 0.4% | +189,200 | New | History |
| IRWDIronwood Pharmaceuticals Inc | COM CL A | 4,438,232 | $18.3M | 0.5% | 00.0% | Unchanged | History |
| IMTXImmatics N.V. | SHS | 1,647,565 | $18.8M | 0.5% | +1,647,565 | New | History |
| OCULOcular Therapeutix, Inc | COM | 2,239,770 | $19.5M | 0.6% | +596,000+36.3% | Added | History |
| EXASExact Sciences Corp | COM | 286,178 | $19.5M | 0.6% | −855,500−74.9% | Reduced | History |
| Amphastar Pharmaceuticals IN03209RAB9 | NOTE 2.000% 3/1 | – | $19.5M | 0.6% | – | New | – |
| CGEMCullinan Therapeutics, Inc. | COM | 1,176,173 | $19.7M | 0.6% | +1,000,000+567.6% | Added | History |
| HROWHarrow, Inc. | COM | 439,638 | $19.8M | 0.6% | +142,450+47.9% | Added | History |
| ATECAlphatec Holdings, Inc. | COM NEW | 4,041,065 | $22.5M | 0.6% | +1,846,165+84.1% | Added | History |
| RLAYRelay Therapeutics, Inc. | COM | 3,499,427 | $24.8M | 0.7% | +492,628+16.4% | Added | History |
| FNAParagon 28, Inc. | COM | 4,135,109 | $27.6M | 0.8% | −15,000−0.4% | Reduced | History |
| BNTXBioNTech SE | SPONSORED ADS | 247,750 | $29.4M | 0.8% | +247,750 | New | History |
| DXCMDexcom Inc | COM | 441,086 | $29.6M | 0.8% | +441,086 | New | History |
| KIDSOrthopediatrics Corp | COM | 1,107,770 | $30.0M | 0.9% | 00.0% | Unchanged | History |
| KRYSKrystal Biotech, Inc. | COM | 168,691 | $30.7M | 0.9% | +61,512+57.4% | Added | History |
| ARVNArvinas, Inc. | COM | 1,284,472 | $31.6M | 0.9% | +767,242+148.3% | Added | History |
| REPLReplimune Group, Inc. | COM | 3,070,837 | $33.7M | 1.0% | +2,057,460+203.0% | Added | History |
| PCVXVaxcyte, Inc. | COM | 297,568 | $34.0M | 1.0% | −510,735−63.2% | Reduced | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 183,818 | $39.0M | 1.1% | +183,818 | New | History |
| GKOSGLAUKOS Corp | COM | 311,616 | $40.6M | 1.2% | −184,960−37.2% | Reduced | History |
| KROSKeros Therapeutics, Inc. | COM | 707,240 | $41.1M | 1.2% | −274,969−28.0% | Reduced | History |
| BCAXBicara Therapeutics Inc. | COM | 1,657,600 | $42.2M | 1.2% | +1,657,600 | New | History |
| AVDLAvadel Pharmaceuticals PLC | Stock | 3,388,939 | $44.4M | 1.3% | +490,300+16.9% | Added | History |
| ISRGIntuitive Surgical Inc | COM NEW | 91,300 | $44.9M | 1.3% | −9,200−9.2% | Reduced | History |
| BridgeBio Pharma, Inc.10806XAD4 | NOTE 2.250% 2/0 | – | $45.0M | 1.3% | – | – | – |
| SRPTSarepta Therapeutics, Inc. | COM | 370,400 | $46.3M | 1.3% | +288,500+352.3% | Added | History |
| INSPInspire Medical Systems, Inc. | COM | 238,911 | $50.4M | 1.4% | −140,532−37.0% | Reduced | History |
| EWTXEdgewise Therapeutics, Inc. | COM | 1,958,310 | $52.3M | 1.5% | +1,958,310 | New | History |
| ARGXArgenx SE | SPONSORED ADR | 96,724 | $52.4M | 1.5% | −70,200−42.1% | Reduced | History |
| Alphatec Hldgs Inc02081GAB8 | NOTE 0.750% 8/0 | – | $52.5M | 1.5% | – | – | – |
| Retrophin Inc761299AB2 | NOTE 2.500% 9/1 | – | $53.5M | 1.5% | – | – | – |
| IRTCiRhythm Holdings, Inc. | COM | 782,557 | $58.1M | 1.6% | +256,200+48.7% | Added | History |
| RGENRepligen Corp | COM | 396,781 | $59.0M | 1.7% | +73,272+22.6% | Added | History |
| SYRESpyre Therapeutics, Inc. | COM NEW | 2,189,836 | $64.4M | 1.8% | −324,702−12.9% | Reduced | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 4,873,853 | $67.9M | 1.9% | +1,837,949+60.5% | Added | History |
| MRVIMaravai Lifesciences Holdings, Inc. | COM CL A | 8,353,287 | $69.4M | 2.0% | −670,750−7.4% | Reduced | History |
| Dexcom Inc252131AK3 | NOTE 0.250%11/1 | – | $70.1M | 2.0% | – | – | – |
| PENPenumbra Inc | COM | 361,428 | $70.2M | 2.0% | +148,834+70.0% | Added | History |
| KNSAKiniksa Pharmaceuticals International, plc | ORD SHS CL A | 2,894,513 | $72.3M | 2.1% | +836,210+40.6% | Added | History |
| VKTXViking Therapeutics, Inc. | COM | 1,156,977 | $73.2M | 2.1% | +50,072+4.5% | Added | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 1,541,551 | $75.1M | 2.1% | −128,169−7.7% | Reduced | History |
| Insulet Corp45784PAK7 | NOTE 0.375% 9/0 | – | $76.4M | 2.2% | – | – | – |
| GHGuardant Health, Inc. | COM | 3,342,124 | $76.7M | 2.2% | +534,156+19.0% | Added | History |
| ALGNAlign Technology Inc | COM | 311,679 | $79.3M | 2.2% | +36,472+13.3% | Added | History |
| Dexcom Inc252131AM9 | NOTE 0.375% 5/1 | – | $82.3M | 2.3% | – | – | – |
| Ironwood Pharmaceuticals Inc46333XAH1 | NOTE 1.500% 6/1 | – | $82.5M | 2.3% | – | – | – |
| APLSApellis Pharmaceuticals, Inc. | COM | 3,125,183 | $90.1M | 2.6% | +2,513,383+410.8% | Added | History |
| APGEApogee Therapeutics, Inc. | COM | 1,643,226 | $96.5M | 2.7% | −748,816−31.3% | Reduced | History |
| Neogenomics Inc64049MAB6 | NOTE 0.250% 1/1 | – | $96.9M | 2.7% | – | – | – |
| NBIXNeurocrine Biosciences Inc | Stock | 917,674 | $105.7M | 3.0% | +158,665+20.9% | Added | History |
| XENEXenon Pharmaceuticals Inc. | COM | 2,707,255 | $106.6M | 3.0% | +146,682+5.7% | Added | History |
| Nuvasive Inc670704AJ4 | NOTE 0.375% 3/1 | – | $111.9M | 3.2% | – | – | – |
| CGONCG Oncology, Inc. | COM | 3,170,875 | $119.6M | 3.4% | −138,632−4.2% | Reduced | History |
| NovoCure Ltd67011XAB9 | NOTE 11/0 | – | $133.3M | 3.8% | – | – | – |
| BridgeBio Pharma, Inc.10806XAB8 | NOTE 2.500% 3/1 | – | $145.6M | 4.1% | – | – | – |
| Guardant Health, Inc.40131MAB5 | NOTE 11/1 | – | $216.0M | 6.1% | – | – | – |
Sold out since Q2 2024 (10)
Positions held at the end of Q2 2024 that are gone from this filing.
| Security | Class | Shares in Q2 2024 | Value in Q2 2024 | % of portfolio in Q2 2024 | History |
|---|---|---|---|---|---|
| Sarepta Therapeutics, Inc.803607AD2 | NOTE 1.250% 9/1 | – | $55.5M | 1.7% | – |
| TMOThermo Fisher Scientific Inc. | Stock | 70,449 | $39.0M | 1.2% | History |
| TMDXTransMedics Group, Inc. | COM | 189,960 | $28.6M | 0.9% | History |
| IMCRImmunocore Holdings plc | ADS | 797,268 | $27.0M | 0.8% | History |
| AKROAkero Therapeutics, Inc. | COM | 1,084,400 | $25.4M | 0.8% | History |
| LIVNLivaNova PLC | SHS | 173,900 | $9.53M | 0.3% | History |
| LBPHLongboard Pharmaceuticals, Inc. | COM | 205,926 | $5.57M | 0.2% | History |
| CONMED Corp207410AH4 | NOTE 2.250% 6/1 | – | $4.48M | 0.1% | – |
| OMOutset Medical, Inc. | COM | 694,525 | $2.67M | 0.1% | History |
| ETNB89bio, Inc. | COM | 164,227 | $1.32M | <0.1% | History |